Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05510908 · OUTCOME

Planned Cancer Therapy for Cancer Patients With HIV Initiating Therapy or Currently Under Treatment

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC · Source last updated 2026-08-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
12 weeks

What was measured

The frequency of planned cancer treatment regimens (at baseline) successfully initiated will be summarized.

Analysis population: Participants who enrolled in this study

Groups in this outcome

New, Primary or Recurrent Disease

Considering or currently receiving cancer treatment Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review. Non-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.

Metastic or Locally Advanced Cancer

This includes cases for which there are no current definitive therapy options for cure (i.e., inoperable) but may be considered for non-standard / non-curative therapies. Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review. Non-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.

Prior Cancer

Prior diagnosis (within 5 years), in remission - Not currently on cancer treatment other than ART or maintenance therapy. Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
New, Primary or Recurrent Disease268
Metastic or Locally Advanced Cancer33
Prior Cancer159

Reported measurements

Planned additional therapy
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
New, Primary or Recurrent Disease95Not reportedNot reportedNot reportedNot reported
Metastic or Locally Advanced Cancer14Not reportedNot reportedNot reportedNot reported
Prior Cancer0Not reportedNot reportedNot reportedNot reported
No additional therapy
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
New, Primary or Recurrent Disease171Not reportedNot reportedNot reportedNot reported
Metastic or Locally Advanced Cancer18Not reportedNot reportedNot reportedNot reported
Prior Cancer1Not reportedNot reportedNot reportedNot reported
Unknown/missing
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
New, Primary or Recurrent Disease2Not reportedNot reportedNot reportedNot reported
Metastic or Locally Advanced Cancer1Not reportedNot reportedNot reportedNot reported
Prior Cancer158Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        95
      2. group Id
        OG001
        value
        14
      3. group Id
        OG002
        value
        0
    title
    Planned additional therapy
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        171
      2. group Id
        OG001
        value
        18
      3. group Id
        OG002
        value
        1
    title
    No additional therapy
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        2
      2. group Id
        OG001
        value
        1
      3. group Id
        OG002
        value
        158
    title
    Unknown/missing
denoms
  1. counts
    1. group Id
      OG000
      value
      268
    2. group Id
      OG001
      value
      33
    3. group Id
      OG002
      value
      159
    units
    Participants
description
The frequency of planned cancer treatment regimens (at baseline) successfully initiated will be summarized.
groups
  1. description
    Considering or currently receiving cancer treatment Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review. Non-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.
    id
    OG000
    title
    New, Primary or Recurrent Disease
  2. description
    This includes cases for which there are no current definitive therapy options for cure (i.e., inoperable) but may be considered for non-standard / non-curative therapies. Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review. Non-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.
    id
    OG001
    title
    Metastic or Locally Advanced Cancer
  3. description
    Prior diagnosis (within 5 years), in remission - Not currently on cancer treatment other than ART or maintenance therapy. Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.
    id
    OG002
    title
    Prior Cancer
param Type
COUNT_OF_PARTICIPANTS
population Description
Participants who enrolled in this study
reporting Status
POSTED
time Frame
12 weeks
title
Planned Cancer Therapy for Cancer Patients With HIV Initiating Therapy or Currently Under Treatment
type
OTHER_PRE_SPECIFIED
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice